INR 3.25
(4.84%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 2.01 Million INR | -75.35% |
2022 | 8.16 Million INR | -4.66% |
2021 | 8.56 Million INR | 236.85% |
2020 | 2.54 Million INR | 303.65% |
2019 | 630 Thousand INR | 51.08% |
2018 | 417 Thousand INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 8.26 Million INR | 0.0% |
2023 Q1 | 3.46 Million INR | -57.61% |
2023 FY | 2.01 Million INR | -75.34% |
2023 Q3 | 2.01 Million INR | -41.83% |
2023 Q4 | 2.01 Million INR | -0.05% |
2023 Q2 | 3.46 Million INR | 0.0% |
2022 Q1 | 14.87 Million INR | 73.35% |
2022 FY | 8.16 Million INR | -4.66% |
2022 Q4 | 8.16 Million INR | -0.01% |
2022 Q3 | 8.16 Million INR | -45.09% |
2022 Q2 | 14.87 Million INR | 0.0% |
2021 Q1 | 13.9 Million INR | 0.0% |
2021 FY | 8.56 Million INR | 236.85% |
2021 Q4 | 8.58 Million INR | 0.18% |
2021 Q3 | 8.56 Million INR | -38.39% |
2021 Q2 | 13.9 Million INR | 0.0% |
2020 FY | 2.54 Million INR | 303.65% |
2019 FY | 630 Thousand INR | 51.08% |
2018 FY | 417 Thousand INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 16.27 Billion INR | 99.988% |
Aurobindo Pharma Limited | 152.2 Billion INR | 99.999% |
Glenmark Life Sciences Limited | 5.18 Billion INR | 99.961% |
Granules India Limited | 22.95 Billion INR | 99.991% |
Indoco Remedies Limited | 10.34 Billion INR | 99.981% |
Ajanta Pharma Limited | 10.71 Billion INR | 99.981% |
Alkem Laboratories Limited | 48.6 Billion INR | 99.996% |
Alpa Laboratories Limited | 307.12 Million INR | 99.345% |
Brooks Laboratories Limited | 248.6 Million INR | 99.19% |
AstraZeneca Pharma India Limited | 3.66 Billion INR | 99.945% |
Bajaj HealthCare Limited | 4.86 Billion INR | 99.959% |
Bliss GVS Pharma Limited | 2.1 Billion INR | 99.905% |
Dr. Reddy's Laboratories Limited | 106.96 Billion INR | 99.998% |
Eris Lifesciences Limited | 38.26 Billion INR | 99.995% |
FDC Limited | 3.7 Billion INR | 99.946% |
Glenmark Pharmaceuticals Limited | 65.11 Billion INR | 99.997% |
Gufic Biosciences Limited | 5.59 Billion INR | 99.964% |
Ind-Swift Laboratories Limited | 2.28 Billion INR | 99.912% |
Ipca Laboratories Limited | 33.74 Billion INR | 99.994% |
Jagsonpal Pharmaceuticals Limited | 296.76 Million INR | 99.322% |
Krebs Biochemicals & Industries Limited | 2.97 Billion INR | 99.932% |
Lasa Supergenerics Limited | 541.92 Million INR | 99.629% |
Laurus Labs Limited | 42.71 Billion INR | 99.995% |
Lupin Limited | 96.23 Billion INR | 99.998% |
Mankind Pharma Limited | 23.87 Billion INR | 99.992% |
Medicamen Biotech Limited | 940.36 Million INR | 99.786% |
Medico Remedies Limited | 438.24 Million INR | 99.541% |
Megasoft Limited | 1.85 Billion INR | 99.891% |
NATCO Pharma Limited | 10.53 Billion INR | 99.981% |
Piramal Pharma Limited | 74 Billion INR | 99.997% |
RPG Life Sciences Limited | 1.38 Billion INR | 99.854% |
Sigachi Industries Limited | 2.53 Billion INR | 99.92% |
Sun Pharmaceutical Industries Limited | 183.56 Billion INR | 99.999% |
Suven Pharmaceuticals Limited | 2.03 Billion INR | 99.901% |
Syncom Formulations (India) Limited | 1.16 Billion INR | 99.827% |
Unichem Laboratories Limited | 8.06 Billion INR | 99.975% |
Wanbury Limited | 3.15 Billion INR | 99.936% |
Windlas Biotech Limited | 1.76 Billion INR | 99.886% |
ZIM Laboratories Limited | 2.08 Billion INR | 99.903% |
Zydus Lifesciences Limited | 71.79 Billion INR | 99.997% |
Sun Pharma Advanced Research Company Limited | 3.89 Billion INR | 99.948% |
Divi's Laboratories Limited | 18.99 Billion INR | 99.989% |
Hester Biosciences Limited | 3.59 Billion INR | 99.944% |
Procter & Gamble Health Limited | 2.56 Billion INR | 99.921% |
Amrutanjan Health Care Limited | 783.82 Million INR | 99.743% |
Bal Pharma Limited | 2.51 Billion INR | 99.92% |
Strides Pharma Science Limited | 37.68 Billion INR | 99.995% |
Venus Remedies Limited | 1.39 Billion INR | 99.855% |
Aarti Pharmalabs Limited | 8.25 Billion INR | 99.976% |
Nectar Lifesciences Limited | 11.21 Billion INR | 99.982% |
Shilpa Medicare Limited | 12.93 Billion INR | 99.984% |
Aarti Drugs Limited | 11.5 Billion INR | 99.983% |
IOL Chemicals and Pharmaceuticals Limited | 6.32 Billion INR | 99.968% |
Suven Life Sciences Limited | 148.62 Million INR | 98.646% |
Ind-Swift Limited | 13.45 Billion INR | 99.985% |
Valiant Laboratories Limited | 1.05 Billion INR | 99.81% |
J. B. Chemicals & Pharmaceuticals Limited | 10.7 Billion INR | 99.981% |
Solara Active Pharma Sciences Limited | 14.14 Billion INR | 99.986% |
Themis Medicare Limited | 1.88 Billion INR | 99.893% |
Hikal Limited | 12.99 Billion INR | 99.985% |
Torrent Pharmaceuticals Limited | 82.05 Billion INR | 99.998% |
Sequent Scientific Limited | 8.27 Billion INR | 99.976% |
Novartis India Limited | 1.8 Billion INR | 99.888% |
Wockhardt Limited | 39.87 Billion INR | 99.995% |
Jubilant Pharmova Limited | 61.27 Billion INR | 99.997% |
Biofil Chemicals and Pharmaceuticals Limited | 288.79 Million INR | 99.303% |
Neuland Laboratories Limited | 5.49 Billion INR | 99.963% |
Morepen Laboratories Limited | 4.45 Billion INR | 99.955% |
Kilitch Drugs (India) Limited | 643.88 Million INR | 99.687% |
Mangalam Drugs & Organics Limited | 1.97 Billion INR | 99.898% |